Nanobiotix S.A.

NASDAQ: NBTX · Real-Time Price · USD
8.14
-0.06 (-0.73%)
At close: Aug 15, 2025, 3:59 PM
8.26
1.47%
After-hours: Aug 15, 2025, 07:56 PM EDT

Nanobiotix S.A. Income Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
Revenue
-20.9M 9.29M 32.91M 3.29M 1.72M 664.5K 664K 10K
Cost of Revenue
n/a n/a n/a n/a 754K 746K 759K -649.5K
Gross Profit
-20.9M 9.29M 32.91M 3.29M 969.5K -81.5K -95K 659.5K
Operating Income
-44.74M -23.65M -1.41M -25.37M -24.25M -26.25M -24.13M -25.67M
Interest Income
2.63M n/a n/a n/a 250K 1.36M 1.22M 1.56M
Pretax Income
-46.3M -21.73M -11.48M -28.1M -33.72M -27.4M -17.84M -31.64M
Net Income
-46.26M -21.87M -11.6M -28.1M -30.68M -26.36M -16.58M -30.42M
Selling & General & Admin
9.23M 10.83M 11.19M 10.86M 7.98M 9.49M 9.02M 10M
Research & Development
18.55M 21.99M 20.59M 17.8M 15.53M 15.94M 14.35M 14.88M
Other Expenses
-3.94M 121K 2.55M -6K 25K -68K n/a n/a
Operating Expenses
23.84M 32.94M 34.32M 28.66M 23.49M 25.5M 23.37M 24.88M
Interest Expense
8.09M n/a n/a n/a 3.11M n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
23.84M 32.94M 34.32M 28.66M 24.25M 26.25M 24.13M 25.68M
Income Tax Expense
-43K 144K 117K 3K -3.03M -1.05M -1.26M -1.23M
Shares Outstanding (Basic)
47.27M 47.12M 37.99M 35.04M 34.85M 34.84M 34.81M 34.62M
Shares Outstanding (Diluted)
47.27M 47.12M 38.82M 35.04M 34.85M 34.84M 34.81M 34.62M
EPS (Basic)
-0.98 -0.46 -0.3 -0.8 -0.88 -0.76 -0.48 -0.88
EPS (Diluted)
-0.98 -0.46 -0.31 -0.8 -0.88 -0.76 -0.48 -0.88
EBITDA
-35.08M -23.24M 1.41M -24.64M -10.26M -12.09M -10.55M -11.78M
EBIT
-36.41M -23.53M 1.14M -25.38M -10.4M -12.46M -11.4M -12.18M
Depreciation & Amortization
1.33M 287K 274K 741K 754K 746K 759K 801K